ArticleFrontiers in cell and developmental biology2021

PARP1 Inhibitor Combined With Oxaliplatin Efficiently Suppresses Oxaliplatin Resistance in Gastric Cancer-Derived Organoids via Homologous Recombination and the Base Excision Repair Pathway.

Huafu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.